TreeWAS – Variant ID: rs7158359

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G95.9 Disease of spinal cord, unspecified	0.040	0.960	0.000
G95 Other diseases of spinal cord	0.039	0.961	0.000
K86.8 Other specified diseases of pancreas	0.039	0.961	0.000
G95.1 Vascular myelopathies	0.037	0.963	0.000
K86 Other diseases of pancreas	0.037	0.963	0.000
G95.8 Other specified diseases of spinal cord	0.036	0.964	0.000
K86.2 Cyst of pancreas	0.034	0.966	0.000
K86.1 Other chronic pancreatitis	0.034	0.966	0.000
G95.0 Syringomyelia and syringobulbia	0.033	0.967	0.000
J02.9 Acute pharyngitis, unspecified	0.030	0.970	0.000
G95.2 Cord compression, unspecified	0.030	0.970	0.000
K86.3 Pseudocyst of pancreas	0.029	0.971	0.000
K86.9 Disease of pancreas, unspecified	0.027	0.973	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.027	0.973	0.000
S42.00 Fracture of clavicle (closed)	0.017	0.983	0.000
J02 Acute pharyngitis	0.016	0.984	0.000
S42.0 Fracture of clavicle	0.015	0.985	0.000
K11.2 Sialoadenitis	0.000	0.986	0.014
K61.0 Anal abscess	0.013	0.987	0.000
S42 Fracture of shoulder and upper arm	0.013	0.987	0.000
G90-G99 Other disorders of the nervous system	0.013	0.987	0.000
J02.0 Streptococcal pharyngitis	0.012	0.988	0.000
J02.8 Acute pharyngitis due to other specified organisms	0.012	0.988	0.000
S41 Open wound of shoulder and upper arm	0.011	0.989	0.000
S41.1 Open wound of upper arm	0.011	0.989	0.000
S40-S49 Injuries to the shoulder and upper arm	0.011	0.989	0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.011	0.989	0.000
S42.1 Fracture of scapula	0.011	0.989	0.000
K11 Diseases of salivary glands	0.000	0.989	0.011
S42.01 Fracture of clavicle (open)	0.011	0.989	0.000
S42.7 Multiple fractures of clavicle, scapula and humerus	0.010	0.990	0.000
K61 Abscess of anal and rectal regions	0.010	0.990	0.000
G96 Other disorders of central nervous system	0.010	0.990	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.010	0.990	0.000
G97.8 Other postprocedural disorders of nervous system	0.010	0.990	0.000
K61.3 Ischiorectal abscess	0.010	0.990	0.000
S49 Other and unspecified injuries of shoulder and upper arm	0.010	0.990	0.000
S42.9 Fracture of shoulder girdle, part unspecified	0.010	0.990	0.000
K11.1 Hypertrophy of salivary gland	0.000	0.990	0.010
S42.8 Fracture of other parts of shoulder and upper arm	0.009	0.990	0.000
S41.0 Open wound of shoulder	0.009	0.990	0.000
G92 Toxic encephalopathy	0.009	0.991	0.000
S46 Injury of muscle and tendon at shoulder and upper arm level	0.009	0.991	0.000
G90 Disorders of autonomic nervous system	0.009	0.991	0.000
S42.10 Fracture of scapula (closed)	0.009	0.991	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.009	0.991	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.009	0.991	0.000
S42.4 Fracture of lower end of humerus	0.009	0.991	0.000
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.000	0.991	0.009
K11.5 Sialolithiasis	0.000	0.991	0.009
K11.9 Disease of salivary gland, unspecified	0.000	0.991	0.009
S42.2 Fracture of upper end of humerus	0.009	0.991	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
G97.0 Cerebrospinal fluid leak from spinal puncture	0.009	0.991	0.000
S42.3 Fracture of shaft of humerus	0.009	0.991	0.000
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.009	0.991	0.000
K11.6 Mucocele of salivary gland	0.000	0.991	0.009
G94 Other disorders of brain in diseases classified elsewhere	0.008	0.991	0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.009	0.991	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.009	0.991	0.000
S49.9 Unspecified injury of shoulder and upper arm	0.008	0.991	0.000
S41.8 Open wound of other and unspecified parts of shoulder girdle	0.008	0.992	0.000
S41.7 Multiple open wounds of shoulder and upper arm	0.008	0.992	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.008	0.992	0.000
L90.5 Scar conditions and fibrosis of skin	0.008	0.992	0.000
K11.7 Disturbances of salivary secretion	0.000	0.992	0.008
S48 Traumatic amputation of shoulder and upper arm	0.008	0.992	0.000
S45 Injury of blood vessels at shoulder and upper arm level	0.008	0.992	0.000
S44 Injury of nerves at shoulder and upper arm level	0.008	0.992	0.000
S47 Crushing injury of shoulder and upper arm	0.008	0.992	0.000
G97.9 Postprocedural disorder of nervous system, unspecified	0.008	0.992	0.000
G97.2 Intracranial hypotension following ventricular shunting	0.008	0.992	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.008	0.992	0.000
K61.2 Anorectal abscess	0.008	0.992	0.000
K61.4 Intrasphincteric abscess	0.008	0.992	0.000
S42.11 Fracture of scapula (open)	0.008	0.992	0.000
K11.4 Fistula of salivary gland	0.000	0.992	0.008
K11.0 Atrophy of salivary gland	0.000	0.992	0.008
K11.8 Other diseases of salivary glands	0.000	0.992	0.008
K61.1 Rectal abscess	0.008	0.992	0.000
B02.9 Zoster without complication	0.008	0.992	0.000
S46.1 Injury of muscle and tendon of long head of biceps	0.008	0.992	0.000
G90.9 Disorder of autonomic nervous system, unspecified	0.008	0.992	0.000
S42.71 Multiple fractures of clavicle, scapula and humerus (open)	0.008	0.992	0.000
G96.8 Other specified disorders of central nervous system	0.008	0.992	0.000
G96.9 Disorder of central nervous system, unspecified	0.007	0.992	0.000
S49.8 Other specified injuries of shoulder and upper arm	0.007	0.992	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.007	0.992	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.007	0.992	0.000
S46.8 Injury of other muscles and tendons at shoulder and upper arm level	0.007	0.992	0.000
G96.0 Cerebrospinal fluid leak	0.007	0.993	0.000
S43.4 Sprain and strain of shoulder joint	0.007	0.993	0.000
S42.90 Fracture of shoulder girdle, part unspecified (closed)	0.007	0.993	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.007	0.993	0.000
Z95.2 Presence of prosthetic heart valve	0.007	0.993	0.000
S49.7 Multiple injuries of shoulder and upper arm	0.007	0.993	0.000
S43.5 Sprain and strain of acromioclavicular joint	0.007	0.993	0.000
Y52 Agents primarily affecting the cardiovascular system	0.007	0.993	0.000
S42.91 Fracture of shoulder girdle, part unspecified (open)	0.007	0.993	0.000
G90.8 Other disorders of autonomic nervous system	0.007	0.993	0.000
G93 Other disorders of brain	0.007	0.993	0.000
S42.81 Fracture of other parts of shoulder and upper arm (open)	0.007	0.993	0.000
S42.80 Fracture of other parts of shoulder and upper arm (closed)	0.007	0.993	0.000
S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level	0.007	0.993	0.000
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level	0.007	0.993	0.000
S46.3 Injury of muscle and tendon of triceps	0.007	0.993	0.000
G90.4 Autonomic dysreflexia	0.007	0.993	0.000
G90.1 Familial dysautonomia [Riley-Day]	0.007	0.993	0.000
K11.3 Abscess of salivary gland	0.000	0.993	0.007
G99.2 Myelopathy in diseases classified elsewhere	0.007	0.993	0.000
G90.2 Horner's syndrome	0.007	0.993	0.000
G93.0 Cerebral cysts	0.007	0.993	0.000
S42.21 Fracture of upper end of humerus (open)	0.007	0.993	0.000
S42.40 Fracture of lower end of humerus (closed)	0.007	0.993	0.000
S42.31 Fracture of shaft of humerus (open)	0.006	0.993	0.000
G94.2 Hydrocephalus in other diseases classified elsewhere	0.006	0.993	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.006	0.993	0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.006	0.994	0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.006	0.994	0.000
S43.7 Sprain and strain of other and unspecified parts of shoulder girdle	0.006	0.994	0.000
S43.6 Sprain and strain of sternoclavicular joint	0.006	0.994	0.000
S43.3 Dislocation of other and unspecified parts of shoulder girdle	0.006	0.994	0.000
S43.2 Dislocation of sternoclavicular joint	0.006	0.994	0.000
S42.41 Fracture of lower end of humerus (open)	0.006	0.994	0.000
G93.3 Postviral fatigue syndrome	0.006	0.994	0.000
S44.9 Injury of unspecified nerve at shoulder and upper arm level	0.006	0.994	0.000
S44.8 Injury of other nerves at shoulder and upper arm level	0.006	0.994	0.000
S44.7 Injury of multiple nerves at shoulder and upper arm level	0.006	0.994	0.000
S44.5 Injury of cutaneous sensory nerve at shoulder and upper arm level	0.006	0.994	0.000
S44.4 Injury of musculocutaneous nerve	0.006	0.994	0.000
S44.3 Injury of axillary nerve	0.006	0.994	0.000
S44.2 Injury of radial nerve at upper arm level	0.006	0.994	0.000
S44.1 Injury of median nerve at upper arm level	0.006	0.994	0.000
S44.0 Injury of ulnar nerve at upper arm level	0.006	0.994	0.000
S45.9 Injury of unspecified blood vessel at shoulder and upper arm level	0.006	0.994	0.000
S45.8 Injury of other blood vessels at shoulder and upper arm level	0.006	0.994	0.000
S45.7 Injury of multiple blood vessels at shoulder and upper arm level	0.006	0.994	0.000
S45.3 Injury of superficial vein at shoulder and upper arm level	0.006	0.994	0.000
S45.2 Injury of axillary or brachial vein	0.006	0.994	0.000
S45.1 Injury of brachial artery	0.006	0.994	0.000
S45.0 Injury of axillary artery	0.006	0.994	0.000
S48.9 Traumatic amputation of shoulder and upper arm, level unspecified	0.006	0.994	0.000
S48.1 Traumatic amputation at level between shoulder and elbow	0.006	0.994	0.000
S48.0 Traumatic amputation at shoulder joint	0.006	0.994	0.000
G90.3 Multisystem degeneration	0.006	0.994	0.000
S43.1 Dislocation of acromioclavicular joint	0.006	0.994	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
S42.20 Fracture of upper end of humerus (closed)	0.006	0.994	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.006	0.994	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.994	0.000
S40 Superficial injury of shoulder and upper arm	0.006	0.994	0.000
S42.30 Fracture of shaft of humerus (closed)	0.006	0.994	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.006	0.994	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
C22.0 Liver cell carcinoma	0.006	0.994	0.000
Y45.0 Opioids and related analgesics	0.006	0.994	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.005	0.994	0.000
Y52.1 Calcium-channel blockers	0.005	0.994	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
Y52.7 Peripheral vasodilators	0.005	0.995	0.000
G94.1 Hydrocephalus in neoplastic disease	0.005	0.995	0.000
G93.7 Reye's syndrome	0.005	0.995	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.005	0.995	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
G93.2 Benign intracranial hypertension	0.005	0.995	0.000
K60.2 Anal fissure, unspecified	0.000	0.995	0.005
G93.5 Compression of brain	0.005	0.995	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.005	0.995	0.000
B02 Zoster [herpes zoster]	0.005	0.995	0.000
J00-J06 Acute upper respiratory infections	0.005	0.995	0.000
J01 Acute sinusitis	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
S46.0 Injury of tendon of the rotator cuff of shoulder	0.005	0.995	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
K85.9 Acute pancreatitis, unspecified	0.005	0.995	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.005	0.995	0.000
H33.0 Retinal detachment with retinal break	0.000	0.995	0.005
S43.0 Dislocation of shoulder joint	0.005	0.995	0.000
S40.8 Other superficial injuries of shoulder and upper arm	0.004	0.995	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.995	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.995	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.995	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.995	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.995	0.000
Y51.0 Anticholinesterase agents	0.004	0.995	0.000
K83 Other diseases of biliary tract	0.005	0.995	0.000
K85 Acute pancreatitis	0.005	0.995	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.995	0.000
J01.1 Acute frontal sinusitis	0.004	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.995	0.000
K83.1 Obstruction of bile duct	0.005	0.995	0.000
G91 Hydrocephalus	0.004	0.995	0.000
G93.6 Cerebral oedema	0.004	0.996	0.000
S40.7 Multiple superficial injuries of shoulder and upper arm	0.004	0.996	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
B02.2 Zoster with other nervous system involvement	0.004	0.996	0.000
G93.4 Encephalopathy, unspecified	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y45.4 Antirheumatics	0.004	0.996	0.000
Y43 Primarily systemic agents	0.004	0.996	0.000
Y53.6 Antidiarrhoeal drugs	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
J01.0 Acute maxillary sinusitis	0.004	0.996	0.000
K83.8 Other specified diseases of biliary tract	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.004	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
Y43.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.004	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
D47.2 Monoclonal gammopathy	0.004	0.996	0.000
K83.9 Disease of biliary tract, unspecified	0.004	0.996	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.004	0.996	0.000
J01.9 Acute sinusitis, unspecified	0.004	0.996	0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.004	0.996	0.000
X59 Exposure to unspecified factor	0.004	0.996	0.000
K85.8 Other acute pancreatitis	0.004	0.996	0.000
J01.2 Acute ethmoidal sinusitis	0.004	0.996	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
B02.8 Zoster with other complications	0.004	0.996	0.000
B02.7 Disseminated zoster	0.004	0.996	0.000
B02.1 Zoster meningitis	0.004	0.996	0.000
B02.0 Zoster encephalitis	0.004	0.996	0.000
X58.9 Unspecified place	0.004	0.996	0.000
J01.8 Other acute sinusitis	0.004	0.996	0.000
J01.4 Acute pansinusitis	0.004	0.996	0.000
J01.3 Acute sphenoidal sinusitis	0.004	0.996	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
X59.3 Sports and athletics area	0.004	0.996	0.000
X59.2 School, other institution and public administrative area	0.004	0.996	0.000
Y46.2 Hydantoin derivatives	0.004	0.996	0.000
Y59.3 Immunoglobulin	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.004	0.996	0.000
J04 Acute laryngitis and tracheitis	0.004	0.996	0.000
X58 Exposure to other specified factors	0.004	0.996	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y53.7 Emetics	0.004	0.996	0.000
Y53.5 Digestants	0.004	0.996	0.000
Y53.3 Saline and osmotic laxatives	0.004	0.996	0.000
Y53.2 Stimulant laxatives	0.004	0.996	0.000
Y53.0 Histamine H2-receptor antagonists	0.004	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Y55.0 Oxytocic drugs	0.004	0.996	0.000
Y47.1 Benzodiazepines	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.996	0.000
K85.2 Alcohol-induced acute pancreatitis	0.004	0.996	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.004	0.996	0.000
K83.4 Spasm of sphincter of Oddi	0.004	0.996	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.996	0.000
Z92.1 Personal history of long-term (current) use of anticoagulants	0.004	0.996	0.000
K83.5 Biliary cyst	0.003	0.996	0.000
K83.3 Fistula of bile duct	0.003	0.996	0.000
K83.2 Perforation of bile duct	0.003	0.996	0.000
K85.3 Drug-induced acute pancreatitis	0.003	0.996	0.000
K85.0 Idiopathic acute pancreatitis	0.003	0.996	0.000
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.003	0.996	0.000
Y43.4 Immunosuppressive agents	0.003	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.996	0.000
Y59.2 Protozoal vaccines	0.003	0.996	0.000
Y59.1 Rickettsial vaccines	0.003	0.996	0.000
Y59.0 Viral vaccines	0.003	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.996	0.000
Y47.4 Bromine compounds	0.003	0.996	0.000
Y47.3 Paraldehyde	0.003	0.996	0.000
Y47.2 Chloral derivatives	0.003	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.996	0.000
B02.3 Zoster ocular disease	0.003	0.996	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.003	0.996	0.000
G93.8 Other specified disorders of brain	0.003	0.996	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
D47.4 Osteomyelofibrosis	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.003	0.997	0.000
G91.8 Other hydrocephalus	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
G93.9 Disorder of brain, unspecified	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
I47.2 Ventricular tachycardia	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
B00.9 Herpesviral infection, unspecified	0.003	0.997	0.000
M34.9 Systemic sclerosis, unspecified	0.000	0.997	0.003
J05.1 Acute epiglottitis	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
J06 Acute upper respiratory infections of multiple and unspecified sites	0.002	0.997	0.001
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.003	0.997	0.000
X59.4 Street and highway	0.003	0.997	0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.003	0.997	0.000
J00 Acute nasopharyngitis [common cold]	0.003	0.997	0.000
G91.0 Communicating hydrocephalus	0.003	0.997	0.000
J05.0 Acute obstructive laryngitis [croup]	0.003	0.997	0.000
X59.9 Unspecified place	0.003	0.997	0.000
X59.8 Other specified place	0.003	0.997	0.000
X59.0 Home	0.003	0.997	0.000
X59.7 Farm	0.003	0.997	0.000
X59.6 Industrial and construction area	0.003	0.997	0.000
X59.5 Trade and service area	0.003	0.997	0.000
X59.1 Residential institution	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
G91.1 Obstructive hydrocephalus	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
C22.1 Intrahepatic bile duct carcinoma	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
G91.2 Normal-pressure hydrocephalus	0.003	0.997	0.000
J04.2 Acute laryngotracheitis	0.003	0.997	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.003	0.997	0.000
X58.8 Other specified place	0.003	0.997	0.000
X58.0 Home	0.003	0.997	0.000
X58.7 Farm	0.003	0.997	0.000
X58.6 Industrial and construction area	0.003	0.997	0.000
X58.5 Trade and service area	0.003	0.997	0.000
X58.4 Street and highway	0.003	0.997	0.000
X58.3 Sports and athletics area	0.003	0.997	0.000
X58.2 School, other institution and public administrative area	0.003	0.997	0.000
X58.1 Residential institution	0.003	0.997	0.000
J04.0 Acute laryngitis	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.997	0.003
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.003	0.997	0.000
V40-V49 Car occupant injured in transport accident	0.003	0.997	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.003	0.997	0.000
K87.1 Disorders of pancreas in diseases classified elsewhere	0.003	0.997	0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.003	0.997	0.000
L90 Atrophic disorders of skin	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
J03 Acute tonsillitis	0.003	0.997	0.000
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
B00 Herpesviral [herpes simplex] infections	0.003	0.997	0.000
J04.1 Acute tracheitis	0.003	0.997	0.000
J45.0 Predominantly allergic asthma	0.000	0.997	0.003
E05.9 Thyrotoxicosis, unspecified	0.000	0.997	0.003
N87.0 Mild cervical dysplasia	0.000	0.997	0.003
S31.8 Open wound of other and unspecified parts of abdomen	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
C22.9 Liver, unspecified	0.003	0.997	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.003	0.997	0.000
K85.1 Biliary acute pancreatitis	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.002	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.002	0.997	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.003	0.997	0.000
C22.7 Other specified carcinomas of liver	0.003	0.997	0.000
C22.4 Other sarcomas of liver	0.003	0.997	0.000
C22.3 Angiosarcoma of liver	0.003	0.997	0.000
C22.2 Hepatoblastoma	0.003	0.997	0.000
S31.0 Open wound of lower back and pelvis	0.003	0.997	0.000
S40.0 Contusion of shoulder and upper arm	0.002	0.997	0.001
Y41.0 Sulphonamides	0.002	0.997	0.000
J06.8 Other acute upper respiratory infections of multiple sites	0.002	0.997	0.001
J06.0 Acute laryngopharyngitis	0.002	0.997	0.001
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.997	0.000
X10-X19 Contact with heat and hot substances	0.003	0.997	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.002	0.997	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.997	0.003
X59.09 Exposure to unspecified factor causing fracture; Unspecified place;	0.002	0.997	0.000
X59.88 Exposure to unspecified factor; Other specified places ;While engaged in other specified activities	0.002	0.997	0.000
X59.99 Exposure to unspecified factor causing other and unspecified injury, Unspecified place	0.002	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
Y00-Y09 Assault	0.002	0.997	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.997	0.003
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
J06.9 Acute upper respiratory infection, unspecified	0.000	0.997	0.002
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.002	0.997	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.002	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.997	0.000
V48 Car occupant injured in noncollision transport accident	0.002	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
Y04 Assault by bodily force	0.002	0.998	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.998	0.000
S31 Open wound of abdomen, lower back and pelvis	0.002	0.998	0.000
X58.01 Exposure to other specified factors: Home: While engaged in leisure activity	0.002	0.998	0.000
X58.89 Exposure to other specified factors: Other specified places: During unspecified activity	0.002	0.998	0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
V70-V79 Bus occupant injured in transport accident	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
B97 Viral agents as the cause of diseases classified to other chapters	0.000	0.998	0.002
I74 Arterial embolism and thrombosis	0.002	0.998	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.002	0.998	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.002	0.998	0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.002	0.998	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
V47 Car occupant injured in collision with fixed or stationary object	0.002	0.998	0.000
V46 Car occupant injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V45 Car occupant injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V41 Car occupant injured in collision with pedal cycle	0.002	0.998	0.000
V40 Car occupant injured in collision with pedestrian or animal	0.002	0.998	0.000
L90.9 Atrophic disorder of skin, unspecified	0.002	0.998	0.000
L90.8 Other atrophic disorders of skin	0.002	0.998	0.000
L90.6 Striae atrophicae	0.002	0.998	0.000
L90.4 Acrodermatitis chronica atrophicans	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations